{"denoms":[{"counts":[{"groupId":"BG000","value":"987"},{"groupId":"BG001","value":"992"},{"groupId":"BG002","value":"1979"}],"units":"Participants"}],"groups":[{"description":"Neoadjuvant total androgen suppression (TAS) - Flutamide and Zoladex or Lupron - two months before and during radiation therapy.","id":"BG000","title":"Hormone Therapy + Radiation Therapy"},{"description":"Radiation therapy alone","id":"BG001","title":"Radiation Therapy Alone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"47","upperLimit":"91","value":"70"},{"groupId":"BG001","lowerLimit":"47","upperLimit":"88","value":"71"},{"groupId":"BG002","lowerLimit":"47","upperLimit":"91","value":"71"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"987"},{"groupId":"BG001","value":"992"},{"groupId":"BG002","value":"1979"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}],"populationDescription":"All eligible patients."}